(Press-News.org) Rutaecarpine, an active component of the traditional Chinese medicine Tetradium ruticarpum, has been shown to improve myocardial ischemia reperfusion injury, mainly focusing on calcitonin gene-based targets. Because both cardiovascular and cerebrovascular diseases are forms of ischemic vascular disease, they are closely related. A recent study reported by Chunlin Yan and colleagues from Hebei North University for the first time investigated the neuroprotective effects and mechanism of action of rutaecarpine on nerve function and learning and memory following cerebral ischemia reperfusion injury. The results from the study verify that rutaecarpine can improve neurological function following cerebral ischemia reperfusion injury, and the mechanism of this improvement may be associated with oxidative stress. These findings, published in the Neural Regeneration Research (Vol. 8, No. 22, 2013), can provide the experimental basis for rutaecarpine to become an ideal drug in the prevention and treatment of cerebral ischemia reperfusion injury.
###
Article: " Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury," by Chunlin Yan, Ji Zhang, Shu Wang, Guiping Xue, Yong Hou (Department of Pharmacology, Hebei North University, Zhangjiakou 075000, Hebei Province, China)
Yan CL, Zhang J, Wang S, Xue GP, Hou Y. Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury. Neural Regen Res. 2013;8(22):2030-2038.
Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/
Full text: http://www.sjzsyj.org/CN/article/downloadArticleFile.do?attachType=PDF&id=674
Does rutaecarpine relieve cerebral ischemia reperfusion injury?
2013-09-16
ELSE PRESS RELEASES FROM THIS DATE:
Carotid endarterectomy for extracranial internal carotid artery occlusion
2013-09-16
Carotid endarterectomy can benefit the majority of patients with severe carotid artery stenosis. However, the therapeutic ef-fects of this technique in patients with symptomatic internal carotid artery occlusion remain controversial. Prof. Feng Ling and team from Capital Medical University retrospectively collected 65 patients with extracranial internal carotid artery occlusion who underwent carotid endarterectomy, carotid endarterectomy combined with Fogarty catheter embolectomy, or hybrid surgery in the Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, ...
White blood cell levels tied to meal time
2013-09-16
A new link between meal times and daily changes in the immune system has been identified by UC San Francisco researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.
A white blood cell of the immune system that is thought to fight parasitic worms might actually help the invaders, according to Richard Locksley, MD, professor of medicine at UCSF and the senior author of the new study, published online today (September 15, 2013) in Nature.
Locksley's lab team found in mice that a type of rare immune cell serves ...
JCI early table of contents for Sept. 16, 2013
2013-09-16
Researchers identify a metabolite as a biomarker of diabetes risk
Type 2 diabetes (T2D) is the most common form of diabetes and is associated with many complications. T2D is preventable through weight control and exercise; however, many individuals are unaware that they are at risk and do not change their lifestyle in time to avoid disease. In this issue of the Journal of Clinical Investigation, Robert Gerszten and colleagues at Massachusetts General Hospital identify the metabolite 2-aminoadipic acid (2-AAA) as a biomarker for T2D diabetes risk. Individuals with increased ...
Researchers identify a metabolite as a biomarker of diabetes risk
2013-09-16
Type 2 diabetes (T2D) is the most common form of diabetes and is associated with many complications. T2D is preventable through weight control and exercise; however, many individuals are unaware that they are at risk and do not change their lifestyle in time to avoid disease.
In this issue of the Journal of Clinical Investigation, Robert Gerszten and colleagues at Massachusetts General Hospital identify the metabolite 2-aminoadipic acid (2-AAA) as a biomarker for T2D diabetes risk. Individuals with increased levels of 2-AAA had a much greater risk of developing diabetes ...
Genotype influences muscle performance
2013-09-16
Elite endurance athletes commonly have mutations that result in the loss of the protein α-actinin-3, which is a major component of fast-twitch muscle fibers. Loss of α-actinin-3 is associated with reduced power, increased endurance capacity, and enhanced response to endurance training.
In this issue of the Journal of Clinical Investigation, Kathryn North and colleagues at the Murdoch Children's Research Institute report that the loss of α-actinin-3 in fast-twitch muscle fibers, results in compensation by α-actinin-2. The presence of α-actinin-2 ...
Arachnophobic entomologists: When 2 more legs make a big difference
2013-09-16
For some entomologists, an apparent paradox exists: Despite choosing a career working with insects, they exhibit negative feelings toward spiders which range from mild disgust to extreme arachnophobia.
An article in the next issue of American Entomologist features the results of a survey involving 41 arachnophobic entomologists who were asked questions about their fear of spiders. Although most entomologists had low scores (indicating mild disgust or mild fear), they still claimed to react differently to spiders than to insects. On the other end of the spectrum, some ...
Chronic inflammation linked to less likelihood of healthy aging
2013-09-16
Chronic exposure to high levels of interleukin-6 was associated with a significantly lower likelihood of healthy aging, according to a study in CMAJ (Canadian Medical Association Journal).
Interleukin-6 is marker of inflammation, and chronic inflammation has been linked to a variety of age-related diseases, such as diabetes, heart disease and cognitive decline. Diet, chronic disease, smoking and other factors can cause inflammation. However, studies on chronic inflammation have generally looked at inflammation at only one point in time.
Researchers analyzed data on ...
Cognitive enhancers do not help mild cognitive impairment
2013-09-16
Cognitive enhancers did not improve cognition and were associated with increased harm in people with mild cognitive impairment, according to a study published in CMAJ (Canadian Medical Association Journal).
Mild cognitive impairment is a condition characterized by memory complaints without substantial limitations in everyday activity. With an increasing proportion of people aged 65 years and older and the growing number of those with mild cognitive impairment, health care professionals, patients and informal caregivers are seeking ways to delay the progression of cognitive ...
Prescription drug expenses in Canada are a health-care barrier
2013-09-16
High drug expenses in Canada are a substantial barrier for people to access prescription drugs outside of hospital, states an analysis in CMAJ (Canadian Medical Association Journal).
Canada lacks a national pharmacare program, with drug costs borne by patients and a mix of private and publicly funded drug plans. Most insurance plans require copayments by patients, which can present a barrier to accessing needed drugs. Although provincial governments cover most or all drug costs for seniors and people on social assistance, the "working poor" do not have the same benefits, ...
Cognitive enhancers don't improve cognition, function in people with mild cognitive impairment
2013-09-16
TORONTO, Sept. 16, 2013—Cognitive enhancers—drugs taken to enhance concentration, memory, alertness and moods—do not improve cognition or function in people with mild cognitive impairment in the long term, according to a new study by researchers at St. Michael's Hospital.
In fact, patients on these medications experienced significantly more nausea, diarrhea, vomiting and headaches, according to the study published today in the
Canadian Medical Association Journal.
"Our findings do not support the use of cognitive enhancers for mild cognitive impairment," wrote Dr. ...